Infection remains a major cause of morbidity and mortality among patients with spinal cord injuries (1, 5) . Because of the prolonged hospital stay required for some of these patients, their associated injuries, and the need for urinary drainage, nosocomial infections account for a high proportion of acquired infection in these patients. Outbreaks of infection due to multiply resistant, gram-negative bacilli have been reported from a variety of hospital areas, including neurology wards (2, 7, 14) . Although cross-infection has been implicated in some outbreaks, the ultimate source of infection remains unknown in others (2, 7, 14) .
A high proportion of nosocomial gram-negative bacilli colonizing patients in our spinal cord injury unit (SCIU) are resistant to gentamicin. In this study we report a prospective evaluation of this endemic problem and attempt to establish the mode of spread of these organisms among patients and to determine the contribution of factors such as length of stay and antibiotic use to this spread. We also identify antibiotics likely to be useful in the empiric therapy of serious nosocomial infections in these patients.
MATERIALS AND METHODS
Specimen collection, processing, identification, and susceptibility testing. Fresh, clean voided urine or material obtained from intermittent catheterization or from tubing of patients with indwelling or condom catheters after disinfection of the sampling port was inoculated with a 0.001-ml loop. Rectal, wound, Tables 1 and 2 ). Three colonized with P. maltophilia were in rooms where the organism had previously been isolated from sinks during the initial survey (Fig. 1) . There was no clearly predominant organism in this group of patients; no species accounted for more than three isolates other than P. maltophilia, and no patients were thought to have active infections with gentamicin-resistant, gram-negative bacilli.
Twenty newly admitted patients acquired nosocomial colonization with 52 organisms during their hospitalization (population C, Tables 1 and   2 ). This was clearly related to their length of stay (Fig. 2) The data were analyzed for evidence of cross colonization as described above. Only 13 of 52 nosocomial isolates could be considered to have been acquired by this mechanism, including the P. maltophilia colonization acquired by three patients, apparently from sinks in their rooms (Fig. 1) . Nine instances were due to P. aeruginosa, although one of these is questionable since the organisms in question differed in tetracycline Table 2) . A. calcoaceticus, Escherichia coli, Klebsiella pneumoniae, Morganella morganii, and P. maltophilia colonized the rectum more frequently than did P. aeruginosa, Providencia spp., or Serratia spp. (Table 2) . Only three isolates from the pharynx were identified during the entire study, and two of these were P. maltophilia (Table 2 ). Wounds (mainly pressure sores) only accounted for seven isolates, four of which were P. aeruginosa ( Although most other studies of SCIUs and tween these similar units have addressed specific outbreaks, n general or few prospective studies of an endemic situation not statisti-have been published (9, 11, 12) . Because of the 1. high endemic rate of colonization and infection It organisms with resistant gram-negative bacilli in the SCIU, ), Providen-we initiated such a study. An initial survey of the 7) . In those studies, as in ours, the length of stay appeared to be the most important factor determining nosocomial acquisition (7) . Others have observed that gramnegative bacilli may become part of the endogenous flora of spinal cord injury patients, resulting in prolonged colonization and difficulty in eradicating the organisms from ordinarily noncolonized sites such as the skin (3, 12) .
GRAM-NEGATIVE RODS IN A SPINAL CORD UNIT
The epidemiology observed on our ward could be explained by the transmission of a single plasmid carrying gentamicin resistance and perhaps other markers among endogenous flora. Preliminary studies suggest an endemic plasmid carrying gentamicin resistance in many of the gram-negative bacilli derived from this study (15) . The association of Serratia spp. with nosocomial acquisition may then be explained by the transfer of this marker to a relatively more pathogenic organism during the course of the study. This mechanism has been proposed by Schaberg et al. (13) to explain one outbreak.
As others have observed, Providencia spp., P. aeruginosa, and Serratia spp. were more likely to colonize the urine than other sites, whereas A. calcoaceticus, K. pneumoniae, E. coli, M. morganii, and P. maltophilia were more likely to colonize the rectums in our patients. The lack of pharyngeal colonization observed in our study is of interest and may suggest differences between spinal cord injury patients and other populations, such as nursing home or intensive care unit patients (8, 16) in whom pharyngeal colonization with gram-negative bacilli occurs more frequently. An alternative explanation is that gentamicin-resistant organisms are less likely to colonize the upper respiratory tract than are susceptible strains.
Of the usual antibiotics tested, amikacin, carbenicillin, and cefoxitin appeared to be the most active against our resistant strains. However, none of these would be acceptable as a single agent used in expectant therapy of a potentially serious nosocomial infection in one of our SCIU patients. Our Serratia spp. were generally resistant to all agents tested, including amikacin. Our susceptibility studies with new P-lactams against gentamicin-resistant strains were, in general, consistent with the results of others (4, 10) . Ceftazidime and imipemide were the most active agents tested. The in vitro performance of cefoperazone against these multiply resistant organisms was disappointing. These new ,-lactams offer hope for single-agent therapy of potentially serious nosocomial infections in our SCIU. Clinical studies will be required to confirm this impression. Veterans Administration Medical Center will be required for greater understanding of the spread of resistant gram-negative bacilli among patients. Plasmid analysis of our strains may also provide additional useful epidemiological information.
